Table 3.
Energy metabolism substrates in the serum of patients enrolled with NYHA ≥ III.
| Laboratory Measurements | SM (n=33) | TMZ (n=35) | Control (n=38) | P-value | |
|---|---|---|---|---|---|
| FFA (μmol/l) | baseline | 668.49 ± 235.13 | 649.80 ± 234.30 | 697.42 ± 239.20 | 0.687 |
| 7 d | 452.88 ± 226.62 | 523.09 ± 224.06 | 571.42 ± 209.40 | 0.081 | |
| Glucose (mmol/l) |
baseline | 5.41 ± 1.23 | 5.81 ± 2.44 | 5.38 ± 1.28 | 0.975 |
| 7 d | 5.15 ± 0.95 | 5.76 ± 1.87 | 5.44 ± 1.77 | 0.415 | |
| LA (mmol/l) | baseline | 2.41 ± 1.01 | 2.25 ± 0.75 | 2.11 ± 0.76 | 0.315 |
| 7 d | 1.91 ± 0.69 | 1.91 ± 0.60 | 1.74 ± 0.53 | 0.387 | |
| PA (μg/ml) | baseline | 16.93 ± 7.96 | 16.34 ± 6.10 | 16.82 ± 10.41 | 0.697 |
| 7 d | 14.29 ± 6.93 | 15.20 ± 6.34 | 15.94 ± 9.69 | 0.552 | |
| BCAA (nmol/μl) | baseline | 0.45 ± 0.17 | 0.43 ± 0.17 | 0.44 ± 0.21 | 0.892 |
| 7 d | 0.55 ± 0.17 | 0.46 ± 0.14 | 0.47 ± 0.17 | 0.065 |
Values are expressed as the mean ± SD.